NextGen Vaccines Holding ApS: Financial statements 2023
CVR: 38706721
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
NextGen Vaccines Holding ApS (CVR 38706721) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -67,041 and a net result of DKK -67,580 compared with DKK -51,134 the year before. Equity in the 2023 report amounted to DKK 202,076. The solvency ratio was 1.5%.
- Gross Profit
- DKK -67,041
- Profit/Loss
- DKK -67,580
- Equity
- DKK 202,076
- Total Assets
- DKK 13,370,530
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -67K | -68K | 202K | - |
| 2022 | - | -36K | -51K | 270K | - |
| 2021 | - | -330K | 347K | 321K | - |
| 2020 | - | -335K | -330K | -26K | 0 |
| 2019 | - | -25K | -26K | 304K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
NextGen Vaccines Holding ApS has published its annual report for 2022. Gross profit came to DKK -35,844, and the net result was DKK -51,134.
About NextGen Vaccines Holding ApS
NextGen Vaccines Holding ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Adam Frederik Sander Bertelsen. The board consists of Morten Agertoug Nielsen (chair), Adam Frederik Sander Bertelsen, Ali El-Salanti and Jacob Hjulmand. The company's owners include Ali El-Salanti, Morten Agertoug Nielsen and Adam Frederik Sander Bertelsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -29,096 and a net result of DKK -51,555 compared with DKK 28,029,025 the year before. Equity in the 2025 report amounted to DKK 229,546.